Abstract
568P First-line (1L) osimertinib + platinum-pemetrexed in EGFR-mutated (EGFRm) advanced NSCLC: Updated FLAURA2 safety run-in (SRI) results
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have